Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Lorenzo Iughetti, Barbara Predieri, Patrizia Bruzzi & Fiorella Balli. (2008) Approaches to dyslipidemia treatment in children and adolescents. Expert Review of Endocrinology & Metabolism 3:5, pages 615-633.
Read now
Read now
Michael H Davidson. (2007) The use of colesevelam hydrochloride in the treatment of dyslipidemia: a review. Expert Opinion on Pharmacotherapy 8:15, pages 2569-2578.
Read now
Read now
Articles from other publishers (15)
Muhammad Shahidul Islam, Anjiya Sharif, Nathania Kwan & Kam C. Tam. (2022) Bile Acid Sequestrants for Hypercholesterolemia Treatment Using Sustainable Biopolymers: Recent Advances and Future Perspectives. Molecular Pharmaceutics 19:5, pages 1248-1272.
Crossref
Crossref
David Sarchet & Justine Bold. (2022) An opportunity for integrative approaches: an examination of the perspectives of women with Bile acid malabsorption (BAM). Advances in Integrative Medicine 9:2, pages 97-102.
Crossref
Crossref
Isabella Ellinger & Waranya Chatuphonprasert. 2022. Cholesterol. Cholesterol
403
450
.
Donatella Zodda, Rosario Giammona & Silvia Schifilliti. (2018) Treatment Strategy for Dyslipidemia in Cardiovascular Disease Prevention: Focus on Old and New Drugs. Pharmacy 6:1, pages 10.
Crossref
Crossref
Chiara Mameli, Gian Vincenzo Zuccotti, Carla Carnovale, Erica Galli, Pilar Nannini, Davide Cervia & Cristiana Perrotta. (2017) An update on the assessment and management of metabolic syndrome, a growing medical emergency in paediatric populations. Pharmacological Research 119, pages 99-117.
Crossref
Crossref
Peter P. Toth, Dragana Nikolic, Manfredi Rizz, Jacek Rysz & Maciej Banach. 2015. Combination Therapy In Dyslipidemia. Combination Therapy In Dyslipidemia
1
10
.
Michael H. Davidson & Peter P. Toth. 2011. Preventive Cardiology: Companion to Braunwald's Heart Disease. Preventive Cardiology: Companion to Braunwald's Heart Disease
215
229
.
Ronald A. CodarioRonald A. Codario. 2011. Type 2 Diabetes, Pre-Diabetes, and the Metabolic Syndrome. Type 2 Diabetes, Pre-Diabetes, and the Metabolic Syndrome
213
238
.
Prasanth N Surampudi, Prathima Nagireddy & Vivian A Fonseca. (2009) Colesevelam hydrochloride: a bile acid sequestrant for glycemic control and treatment of dyslipidemia in Type 2 diabetes mellitus. Therapy 6:4, pages 475-487.
Crossref
Crossref
Matthew S. Murphy & Timothy O'Brien. 2009. Pharmacology and Therapeutics. Pharmacology and Therapeutics
303
320
.
N. K. GUPTA & J. H. LEWIS. (2008) Review article: the use of potentially hepatotoxic drugs in patients with liver disease. Alimentary Pharmacology & Therapeutics 28:9, pages 1021-1041.
Crossref
Crossref
Susan J. Appel, Natalie A. Floyd & Emily J. Jones. (2007) Reducing Cardiovascular Risk and Managing Dyslipidemia in Women. Nursing for Women's Health 11:6, pages 586-599.
Crossref
Crossref
Dean M. Robinson & Gillian M. Keating. (2012) Colesevelam. American Journal of Cardiovascular Drugs 7:6, pages 471-483.
Crossref
Crossref
Sidharth S. Bhardwaj & Naga Chalasani. (2007) Lipid-Lowering Agents That Cause Drug-Induced Hepatotoxicity. Clinics in Liver Disease 11:3, pages 597-613.
Crossref
Crossref
Brian W. McCrindle, Elaine M. Urbina, Barbara A. Dennison, Marc S. Jacobson, Julia Steinberger, Albert P. Rocchini, Laura L. Hayman & Stephen R. Daniels. (2007) Drug Therapy of High-Risk Lipid Abnormalities in Children and Adolescents. Circulation 115:14, pages 1948-1967.
Crossref
Crossref